NICOLE NEWCOMB: Open Payments
NPI 1265864268 · SANTEE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 24 payments from 10 companies in 2025. Trend: 2023 $447 · 2024 $1,165 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $209 |
| PFIZER INC. | 4 | $87 |
| ABBVIE INC. | 3 | $69 |
| Corcept Therapeutics | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Amgen Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Philips North America LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: ZEPBOUND, MOUNJARO, UBRELVY, Korlym, PREVNAR 20, AIRSUPRA, NURTEC ODT, EVENITY.
Industry payments across CA — which companies pay providers there.
